USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
APOLIFE, INC.
Address:
100 RIVER PLACE, SUITE 6800
DETROIT, MI 48207-
Phone:
(313) 446-2625
URL:
N/A
EIN:
383188530
DUNS:
044306905
Number of Employees:
N/A
Woman-Owned?:
Yes
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $507,532.00 3

Award List:

RECOMBINANT MONOCLONAL ANTIBODIES IN YEAST

Award Year / Program / Phase:
1997 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Motwani, nalini m
Abstract:
The use of monoclonal antibodies (MABs) in diagnostic and therapeutics applications is on the rise; yet there are limitations to the current hybridoma technology. There is a need to develop less expensive, novel and improved technologies for MAb production. The application of recombinant technology… More

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$110,000.00
Agency:
HHS
Principal Investigator:
Robert Blackburn
Abstract:
N/a

Not Available

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$297,532.00
Agency:
HHS
Principal Investigator:
Nalini Motwani – (313) 446-2625
Abstract:
ApoLife is developing yeast platform-Twin Cassette yeast vectors for cost effective manufacturing of antibodies. Using recent collaboration with a company with proprietary S. cerevisiae yeast strains producing homogeneous human N-linked glycosylated proteins, ApoLife will develop commercial scale… More